CD70-Targeted [ 18 F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study
Journal of Nuclear Medicine · 2026
DOI: 10.2967/jnumed.125.270958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Cheng Ma und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Carcinoma, Renal Cell, Kidney Neoplasms, CD27 Ligand. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) frequently metastasizes after surgical resection, and accurate diagnosis of ccRCC metastases remains a significant clinical challenge. This study aims to evaluate the expression of CD70 and carbonic anhydrase IX (CAIX) in pulmonary metastases of ccRCC and assess the value of CD70-targeted [18F]RCCB6 immuno-PET/CT in diagnosing ccRCC metastases.
Methods
We retrospectively reviewed the cases of patients who underwent lung surgery at our hospital between January 2016 and December 2024. Available specimens of pathology-confirmed ccRCC lung metastases were collected and stained for CD70 and CAIX expression. Four of these patients were enrolled to receive CD70-targeted [18F]RCCB6 immuno-PET/CT to detect potential metastases. The diagnostic performance of [18F]RCCB6 immuno-PET/CT was validated in an independent cohort of 51 patients with suspected ccRCC lung metastases.
Results
Of the 13,037 patients who underwent lung surgery, 305 had lung metastases, including 40 patients with ccRCC lung metastases. Immunohistochemical analysis of 28 lung metastasis specimens revealed higher expression of CD70 than CAIX (P < 0.05). Four of the 28 patients received CD70-targeted [18F]RCCB6 immuno-PET/CT imaging, of whom 1 exhibited recurrent multiple pulmonary metastases and 3 showed no evidence of disease. In an independent validation cohort of 51 patients with suspected ccRCC lung metastases, 26 underwent dual-tracer [18F]RCCB6 and [18F]FDG PET/CT. In addition to detecting a greater number of metastases, [18F]RCCB6 demonstrated significantly higher tumor uptake (SUVmax) than did [18F]FDG PET/CT in the lung (7.61 vs. 4.28; P < 0.001), lymph nodes (10.49 vs. 6.30; P < 0.001), and other distant metastases (13.84 vs. 4.92; P < 0.001).
Conclusion
CD70 is a viable biomarker for ccRCC lung metastases. CD70-targeted [18F]RCCB6 immuno-PET/CT accurately detects ccRCC lung metastases and other distant metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; wwei@shsmu.edu.cn zhaoxiaojing@renji.com.
Zitieren
APA
Ma, C., Cao, M., Li, L., Wu, Q., Zhang, Y., Xu, D., An, S., Wu, Y., Wang, C., Guan, Y., Kong, W., Zhang, J., Xie, F., Zhai, W., Huang, G., Liu, J., Zhao, X., & Wei, W. (2026). CD70-Targeted [ 18 F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270958
Vancouver
Ma C, Cao M, Li L, Wu Q, Zhang Y, Xu D, et al. CD70-Targeted [ 18 F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.270958
BibTeX
@article{Ma2026,
author = {Ma, Cheng and Cao, Min and Li, Lianghua and Wu, Qianyun and Zhang, You and Xu, Dongsheng and An, Shuxian and Wu, Yanfei and Wang, Cheng and Guan, Yihui and Kong, Wen and Zhang, Jin and Xie, Fang and Zhai, Wei and Huang, Gang and Liu, Jianjun and Zhao, Xiaojing and Wei, Weijun},
title = {CD70-Targeted [ 18 F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study},
journal = {Journal of Nuclear Medicine},
year = {2026},
doi = {10.2967/jnumed.125.270958}
}
EUVIMED